In millions, except per share items | Dec-31-20 | Dec-30-20 | Dec-31-19 | Dec-30-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| 10-K | 8-K | 10-K | 8-K | 10-K | 10-K | 10-K | 10-K |
Revenues: |
Other | 21.1 | | 20.7 | | 24.4 | | | |
United Kingdom | 5.2 | | 5.0 | | 6.2 | | | |
License fees and services | | | | | | | 24.8 | 25.6 |
Total revenues [+] | 26.4 | 26.4 | 25.8 | 25.8 | 30.6 | 28.8 | 24.8 | 25.6 |
Licensing | | 0.7 | | 1.2 | | | | |
Services | | 25.6 | | 24.5 | | | | |
Contracts | | | | | | | 2.9 | 3.2 |
Revenue growth [+] | 2.3% | | -15.9% | | 6.3% | 16.3% | -3.1% | -13.8% |
Other | 2.1% | | -15.2% | | | | | |
United Kingdom | 3.4% | | -19.0% | | | | | |
License fees and services | | | | | | | -3.1% | -13.8% |
Cost of goods sold | 8.8 | 8.8 | 8.7 | 8.7 | 10.3 | 8.7 | 5.3 | 6.4 |
Gross profit | 17.5 | 17.5 | 17.1 | 17.1 | 20.3 | 20.1 | 19.5 | 19.1 |
Gross margin | 66.5% | 66.5% | 66.3% | 66.3% | 66.2% | 69.9% | 78.6% | 74.8% |
Selling, general and administrative [+] | 11.1 | 11.1 | 12.6 | 12.6 | 13.3 | 11.3 | 8.8 | 9.8 |
Sales and marketing | 6.0 | 6.0 | 7.5 | 7.5 | 6.6 | 5.2 | 5.0 | 5.8 |
General and administrative | 5.1 | 5.1 | 5.1 | 5.1 | 6.7 | 6.1 | 3.9 | 4.0 |
Research and development | 4.3 | 4.3 | 4.6 | 4.6 | 4.2 | 2.0 | 3.0 | 3.8 |
EBITDA [+] | 2.1 | 2.1 | -0.1 | -0.1 | 2.8 | 6.8 | 7.6 | 5.4 |
EBITDA growth | -2803.8% | | -102.8% | | -58.2% | -10.9% | 40.8% | -39.7% |
EBITDA margin | 8.1% | 8.1% | -0.3% | -0.3% | 9.3% | 23.6% | 30.9% | 21.2% |
Depreciation | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.3 | 0.3 | 0.3 |
EBITA | 1.9 | 1.9 | -0.3 | -0.3 | 2.7 | 6.6 | 7.4 | 5.1 |
EBITA margin | 7.3% | 7.3% | -1.0% | -1.0% | 8.9% | 22.8% | 29.8% | 20.0% |
Amortization of intangibles | 0.9 | 0.9 | 0.9 | 0.9 | 1.0 | 0.9 | 0.8 | 0.3 |
EBIT [+] | 1.0 | 1.0 | -1.2 | -1.2 | 1.8 | 5.7 | 6.6 | 4.9 |
EBIT growth | -181.2% | | -168.7% | | -69.2% | -13.7% | 36.1% | -44.1% |
EBIT margin | 3.7% | 3.7% | -4.7% | -4.7% | 5.7% | 19.8% | 26.7% | 19.0% |
Non-recurring items [+] | | | 6.7 | 6.7 | 17.8 | 0.3 | 1.0 | 0.5 |
Asset impairment | | | 6.7 | 6.7 | 17.8 | | | |
Interest expense, net [+] | 0.1 | 0.1 | 0.3 | 0.3 | 0.4 | 0.4 | 0.3 | 0.1 |
Interest expense | 0.1 | 0.1 | 0.3 | 0.3 | 0.5 | 0.4 | 0.3 | 0.1 |
Interest income | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 |
Other income (expense), net [+] | 0.6 | 0.6 | -0.4 | -0.4 | 1.2 | -1.1 | -0.4 | 0.0 |
Gain (loss) on foreign currency transactions | 0.4 | | -0.5 | | 0.8 | -1.1 | -0.6 | 0.0 |
Other | 0.2 | -0.2 | 0.1 | -0.1 | 0.4 | 0.0 | 0.2 | |
Pre-tax income | 1.5 | 1.5 | -8.6 | -8.6 | -15.2 | 3.9 | 4.9 | 4.2 |
Income taxes | 0.8 | 0.8 | 1.1 | 1.1 | -0.4 | 1.4 | 1.5 | 0.9 |
Tax rate | 56.3% | 56.3% | | | 2.8% | 36.1% | 29.8% | 21.7% |
Net income | 0.6 | 0.6 | -9.7 | -9.7 | -14.8 | 2.5 | 3.4 | 3.3 |
Net margin | 2.4% | 2.4% | -37.7% | -37.7% | -48.3% | 8.7% | 13.9% | 12.9% |
|
Basic EPS [+] | $0.05 | $0.05 | ($0.80) | ($0.80) | ($1.22) | $0.21 | $0.29 | $0.28 |
Growth | -106.6% | | -34.7% | | -679.3% | -27.3% | 2.9% | -41.5% |
Diluted EPS [+] | $0.05 | $0.05 | ($0.80) | ($0.80) | ($1.22) | $0.21 | $0.29 | $0.28 |
Growth | -106.6% | | -34.7% | | -681.6% | -26.9% | 4.0% | -41.3% |
|
Dividends per share [+] | | | | | | | $0.22 | $0.44 |
Growth | | | | | | -100.0% | -50.0% | 4.8% |
|
Shares outstanding (basic) [+] | 12.2 | 12.2 | 12.2 | 12.2 | 12.1 | 11.9 | 11.8 | 11.7 |
Growth | 0.2% | | 0.4% | | 1.5% | 0.8% | 1.3% | 0.4% |
Shares outstanding (diluted) [+] | 12.3 | 12.3 | 12.2 | 12.2 | 12.1 | 12.0 | 12.0 | 11.9 |
Growth | 0.9% | | 0.4% | | 1.1% | 0.2% | 0.2% | 0.1% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |